Compounded semaglutide and tirzepatide are not FDA-approved as finished drug products
Data availability Researchers can request access to data from the TriNetX research network through the TriNetX platform ( However, this may involve associated costs, require a data-sharing agreement, and no patient-identifiable information can be accessible
Dosing schedule (per Health Canada ): Starter dose: 0.25 mg once weekly for the first 4 weeks Increase: 0.5 mg after Week 4, if tolerated Further titration: Up to 1 mg or more, depending on your treatment plan The gradual increases, occurring every 4 weeks, are designed to minimize side effects and promote a safer, more sustainable treatment response
Below are some key reasons why this is recognized as an effective weight loss approach: 1
Theres no direct link between muscle loss and cramping, but you should still strive to preserve as much muscle as possible while on a GLP-1